Kathleen Rickard
Chief Tech/Sci/R&D Officer presso VERONA PHARMA PLC
Patrimonio netto: 17 M $ in data 31/03/2024
Profilo
Kathleen Rickard is currently the Chief Medical Officer at Verona Pharma Plc since 2019.
Prior to this, she worked at Aerocrine AB from 2011 to 2019 as the Chief Medical & Compliance Officer.
She also worked at GSK Plc as the VP-Clinical Development & Medical Affairs.
Dr. Rickard holds a doctorate degree from Hahnemann University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
VERONA PHARMA PLC
1.80% | 05/02/2024 | 8 656 336 ( 1.80% ) | 17 M $ | 31/03/2024 |
Posizioni attive di Kathleen Rickard
Società | Posizione | Inizio |
---|---|---|
VERONA PHARMA PLC | Chief Tech/Sci/R&D Officer | 01/02/2019 |
Precedenti posizioni note di Kathleen Rickard
Società | Posizione | Fine |
---|---|---|
AEROCRINE AB | Compliance Officer | 01/01/2019 |
GSK PLC | Corporate Officer/Principal | - |
Formazione di Kathleen Rickard
Hahnemann University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
GSK PLC | Health Technology |
VERONA PHARMA PLC | Health Technology |
Aziende private | 1 |
---|---|
Aerocrine AB
Aerocrine AB Electronic Equipment/InstrumentsElectronic Technology Aerocrine AB operates as a specialty pharmaceutical company focused on respiratory disease. The company was founded by Lars E. Gustafsson, Jon Lundberg, Kjell Alving, and Eddie Weitzberg in November 1997 and is headquartered in Uppsala, Sweden. | Electronic Technology |
- Borsa valori
- Insiders
- Kathleen Rickard